[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 13, 1934

Government Services

JAMA. 1934;103(15):1161. doi:10.1001/jama.1934.02750410051018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Bayer Company Ordered to Cease Unfair Competitive Practices  The Federal Trade Commission has issued an order to the Bayer Company, Inc., New York, to cease and desist from using unfair competitive practices in the sale of its acetylsalicylic acid tablets. The company is directed to cease using language in its printed advertising or radio broadcasting stating or giving the impression that "aspirin" is a trademark of the Bayer company. This order does not apply to advertising or packages to be sold in foreign countries in which the word "aspirin" has been held to be the Bayer Company's valid trademark. A list of seventeen representations are given in the commission's order, which the company is not to use unless properly qualified, limited or explained. Among them are such expressions as "It cannot harm the heart," "Bayer aspirin is always safe," "Take Bayer aspirin for any ache or pain, and take enough

First Page Preview View Large
First page PDF preview
First page PDF preview